Dov Hershkovitz

Summary

Country: Israel

Publications

  1. ncbi request reprint Monogenic pigmentary skin disorders: genetics and pathophysiology
    Dov Hershkovitz
    Center for Translational Genetics, Rappaport Institute for Research in the Medical Sciences, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Isr Med Assoc J 10:713-7. 2008
  2. ncbi request reprint Ondansetron for the prevention of seasickness in susceptible sailors: an evaluation at sea
    Dov Hershkovitz
    Motion Sickness and Human Performance Laboratory, Israel Naval Medical Institute, Haifa, Israel
    Aviat Space Environ Med 80:643-6. 2009
  3. ncbi request reprint Vestibular evoked myogenic potentials and saccular plasticity in divers
    Haim Lavon
    Motion Sickness and Human Performance Laboratory, Israel Naval Medical Institute, Israel Defense Forces Medical Corps, Haifa, Israel
    Aviat Space Environ Med 81:103-6. 2010
  4. doi request reprint Normal colon tissue and colon carcinoma show no difference in heparanase promoter methylation
    Yehudit Peerless
    Institute of Pathology, Rambam Health Care Campus, Haifa, Israel
    Exp Mol Pathol 94:309-13. 2013
  5. ncbi request reprint Vestibular evoked myogenic potential threshold and seasickness susceptibility
    Dror Tal
    Motion Sickness and Human Performance Laboratory, Israel Naval Medical Institute, IDF Medical Corps, Haifa, Israel
    J Vestib Res 16:273-8. 2006
  6. doi request reprint Development of a computerized morphometry application for assessment of the tumor fraction in colon carcinoma tissue samples
    Tova Hershkovitz
    Department of Pediatrics B, B Rappaport Faculty of Medicine, Haifa, Israel
    Appl Immunohistochem Mol Morphol 21:54-8. 2013
  7. doi request reprint Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis
    Alan Yancovitch
    Center for Translational Genetics, Rappaport Institute for Research in the Medical Sciences, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    J Bone Miner Metab 29:621-5. 2011
  8. doi request reprint Disadhesion of epidermal keratinocytes: a histologic clue to palmoplantar keratodermas caused by DSG1 mutations
    Reuven Bergman
    Department of Dermatology, Rambam Medical Center, Haifa, Israel
    J Am Acad Dermatol 62:107-13. 2010
  9. doi request reprint A novel mutation in RASA1 causes capillary malformation and limb enlargement
    Dov Hershkovitz
    Department of Dermatology and Laboratory of Molecular Dermatology, Rambam Health Care Campus, Haifa, Israel
    Arch Dermatol Res 300:385-8. 2008
  10. pmc Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis
    Dov Hershkovitz
    Institute of Pathology, Rambam Health Care Campus, Haifa, Israel
    J Invest Dermatol 131:662-9. 2011

Collaborators

  • Eli Sprecher
  • Dror Tal
  • Reuven Bergman
  • Ronen Bar
  • Edmond Sabo
  • Ofer Ben-Izhak
  • Yehudit Peerless
  • Tova Hershkovitz
  • Alan Yancovitch
  • Edna Efrati
  • Haim Lavon
  • Avshalom Shenhav
  • Einav Simon
  • Margo Whiteford
  • Peter Galloway
  • Esra Kiliç
  • Margareta Indelman
  • Hela Elkin
  • Gil Kaminski-Graif
  • Avi Shupak

Detail Information

Publications11

  1. ncbi request reprint Monogenic pigmentary skin disorders: genetics and pathophysiology
    Dov Hershkovitz
    Center for Translational Genetics, Rappaport Institute for Research in the Medical Sciences, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Isr Med Assoc J 10:713-7. 2008
    ..In the present review, we discuss normal skin pigmentation and the genetic underpinning of selected disorders of hypo- and hyperpigmentation...
  2. ncbi request reprint Ondansetron for the prevention of seasickness in susceptible sailors: an evaluation at sea
    Dov Hershkovitz
    Motion Sickness and Human Performance Laboratory, Israel Naval Medical Institute, Haifa, Israel
    Aviat Space Environ Med 80:643-6. 2009
    ..The purpose of the present study was to evaluate the 5HT3 blocker ondansetron in the prevention of seasickness...
  3. ncbi request reprint Vestibular evoked myogenic potentials and saccular plasticity in divers
    Haim Lavon
    Motion Sickness and Human Performance Laboratory, Israel Naval Medical Institute, Israel Defense Forces Medical Corps, Haifa, Israel
    Aviat Space Environ Med 81:103-6. 2010
    ..The purpose of the present study was to examine possible changes in the sacculocollic reflex of professional divers and to investigate whether there might be diving-induced adaptation of the saccular response...
  4. doi request reprint Normal colon tissue and colon carcinoma show no difference in heparanase promoter methylation
    Yehudit Peerless
    Institute of Pathology, Rambam Health Care Campus, Haifa, Israel
    Exp Mol Pathol 94:309-13. 2013
    ..One of the regulatory mechanisms of heparanase expression is de-methylation on its promoter. In the present study we evaluated the role of heparanase promoter methylation in colon carcinoma...
  5. ncbi request reprint Vestibular evoked myogenic potential threshold and seasickness susceptibility
    Dror Tal
    Motion Sickness and Human Performance Laboratory, Israel Naval Medical Institute, IDF Medical Corps, Haifa, Israel
    J Vestib Res 16:273-8. 2006
    ..Theoretically, increased susceptibility to seasickness may be due to a discrepancy between the various neural systems as a result of reduced otolith responses...
  6. doi request reprint Development of a computerized morphometry application for assessment of the tumor fraction in colon carcinoma tissue samples
    Tova Hershkovitz
    Department of Pediatrics B, B Rappaport Faculty of Medicine, Haifa, Israel
    Appl Immunohistochem Mol Morphol 21:54-8. 2013
    ..In conclusion, we believe that this program can be used for standardizing the evaluation of the tumor cell fraction in colon carcinoma and that its use might aid in making better diagnosis and treatment choices for these patients...
  7. doi request reprint Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis
    Alan Yancovitch
    Center for Translational Genetics, Rappaport Institute for Research in the Medical Sciences, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    J Bone Miner Metab 29:621-5. 2011
    ..Our data expand the spectrum of known mutations in GALNT3 and contribute to a better understanding of the phenotypic manifestations of mutations in this gene...
  8. doi request reprint Disadhesion of epidermal keratinocytes: a histologic clue to palmoplantar keratodermas caused by DSG1 mutations
    Reuven Bergman
    Department of Dermatology, Rambam Medical Center, Haifa, Israel
    J Am Acad Dermatol 62:107-13. 2010
    ..Recent developments in molecular genetics may lead to re-examination of the histopathology of inherited palmoplantar keratodermas (PPKs) based on more precise groupings of the various entities and syndromes...
  9. doi request reprint A novel mutation in RASA1 causes capillary malformation and limb enlargement
    Dov Hershkovitz
    Department of Dermatology and Laboratory of Molecular Dermatology, Rambam Health Care Campus, Haifa, Israel
    Arch Dermatol Res 300:385-8. 2008
    ..A novel mutation in RASA1 was found to underlie the disease in this case. The present results illustrate the extensive degree of phenotypic heterogeneity associated with deleterious mutations in RASA1...
  10. pmc Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis
    Dov Hershkovitz
    Institute of Pathology, Rambam Health Care Campus, Haifa, Israel
    J Invest Dermatol 131:662-9. 2011
    ..In conclusion, our data indicate that SAMD9, an IFN-γ-responsive protein, interacts with RGL2 to diminish the expression of EGR1, a protein of direct relevance to the pathogenesis of ectopic calcification and inflammation...
  11. doi request reprint LNA-based PCR clamping enrichment assay for the identification of KRAS mutations
    Edna Efrati
    Center for Translational Genetics, B Rappaport Institute for Research in the Medical Sciences, Technion Israel Institute of Technology and Rambam Health Care Campus, Haifa, Israel
    Cancer Biomark 8:89-94. 2010
    ..In the present study, we developed a KRAS mutations detection method that is both simple and sensitive...